Status:
COMPLETED
Do Discounted Vouchers for Medical Cannabis Reduce Opioid Use in Adults With Pain
Lead Sponsor:
Vireo Health
Conditions:
Opioid Use
Marijuana
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
This study will examine how discounted vouchers for medical cannabis use affects opioid analgesic use in adults with chronic pain. Our study findings will have critically important implications to sha...
Detailed Description
This study will examine how discounted vouchers for medical cannabis use affects opioid analgesic use in adults with chronic pain. ReLeaf-V is a 4-arm blinded randomized controlled trial (RCT) of 352 ...
Eligibility Criteria
Inclusion
- \>18 years old
- English or Spanish fluency
- active certification for medical cannabis
- intends to have a soft-gel capsule product dispensed at Vireo Health
- medical cannabis qualifying conditions or complications of (a) chronic pain, or (b) pain that degrades health and functional capability as an alternative to opioid use or substance use disorder or (c) severe or chronic pain
- joint or neuropathic pain
- current severe pain
- dispensed opioids analgesics within the last 60 days
- To maintain the integrity of the study, we do not disclose all inclusion criteria to potential participants.
Exclusion
- inability to provide informed consent
- inability to complete study visits over 14 weeks
- terminal illness
- current or prior psychotic disorder
- current or prior buprenorphine or methadone treatment for opioid use disorder
- NYS medical marijuana prescriber does not approve changes to product and dosing recommendations listed on the participant's certification form
- Allergy to tapioca or coconut
- currently pregnant, planning to become pregnant within the next 3 months, or breastfeeding
- a condition that is considered by a pharmacist or medical provider to be a clinical contraindication to medical cannabis use (e.g. unstable cardiac arrhythmia or specific drug-drug interaction)
Key Trial Info
Start Date :
October 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 13 2024
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT04495725
Start Date
October 6 2020
End Date
March 13 2024
Last Update
March 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vireo Health of New York
Queens, New York, United States, 11373